Imran Sulaiman1, Jansen Seheult2, Nirmal Sadasivuni1, Elaine MacHale1, Isabelle Killane3, Spiros Giannoutsos2, Breda Cushen1, Matshediso Constantina Mokoka1, Aoife Sartini Bhreathnach1, Fiona Boland4, Richard B Reilly3,5,6, Richard W Costello1,7. 1. 1 Clinical Research Centre, Royal College of Surgeons in Ireland , Dublin, Ireland . 2. 2 Special Chemistry Division, Department of Pathology, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania. 3. 3 Trinity Centre for Bioengineering, Trinity College, The University of Dublin , Dublin, Ireland . 4. 4 Royal College of Surgeons in Ireland Population Health Sciences , Dublin, Ireland . 5. 5 School of Engineering, Trinity College, The University of Dublin , Dublin, Ireland . 6. 6 School of Medicine, Trinity College, The University of Dublin , Dublin, Ireland . 7. 7 Department of Respiratory Medicine, Royal College of Surgeons in Ireland , Dublin, Ireland .
Abstract
BACKGROUND: Researchers, using checklists, have identified that 30%-90% of patients make errors in inhaler use. It is not certain whether these errors affect the delivery of medication. We have developed an electronic monitor (INCA™) that records audio each time an inhaler is used, providing objective information on inhaler technique. The aim of this study was to assess the effect that correctly identified inhaler errors, with the INCA device, have on drug delivery. METHODS: This was a prospective study of healthy volunteers using a salbutamol Diskus™. The inclusion criteria allowed for the recruitment of healthy participants who were nonfrequent users of Salbutamol. Each participant was assigned to one control "phase" first and two/three subsequent error "phases." Each phase consisted of six doses of the drug taken 6 hours apart, and the participants' blood was drawn before and 25 minutes after doses one and six. This allowed us to sample their trough and peak serum salbutamol levels. RESULTS: Fourteen healthy volunteers were studied. The inhaler technique errors simulated in this study included exhaling into the device after drug priming but before inhalation, low inspiratory flow, multiple inhalations, low breath hold, missed doses, and wrong inhaler position. Only the exhalation error, low inspiratory flow, and missed doses led to a significant reduction in serum salbutamol levels. After six doses of the exhalation error, there was a 62% reduction in peak salbutamol levels. Low inspiratory flow led to a 52% reduction in peak salbutamol levels and a 78% reduction in trough levels. Missed doses led to a 37% reduction in trough salbutamol levels. CONCLUSIONS: These findings confirm that technique errors affect drug delivery. Furthermore, we were able to identify that the most critical technique errors with the Diskus inhaler are exhalation into the device before inhalation, poor inspiratory flow, and missing doses.
BACKGROUND: Researchers, using checklists, have identified that 30%-90% of patients make errors in inhaler use. It is not certain whether these errors affect the delivery of medication. We have developed an electronic monitor (INCA™) that records audio each time an inhaler is used, providing objective information on inhaler technique. The aim of this study was to assess the effect that correctly identified inhaler errors, with the INCA device, have on drug delivery. METHODS: This was a prospective study of healthy volunteers using a salbutamol Diskus™. The inclusion criteria allowed for the recruitment of healthy participants who were nonfrequent users of Salbutamol. Each participant was assigned to one control "phase" first and two/three subsequent error "phases." Each phase consisted of six doses of the drug taken 6 hours apart, and the participants' blood was drawn before and 25 minutes after doses one and six. This allowed us to sample their trough and peak serum salbutamol levels. RESULTS: Fourteen healthy volunteers were studied. The inhaler technique errors simulated in this study included exhaling into the device after drug priming but before inhalation, low inspiratory flow, multiple inhalations, low breath hold, missed doses, and wrong inhaler position. Only the exhalation error, low inspiratory flow, and missed doses led to a significant reduction in serum salbutamol levels. After six doses of the exhalation error, there was a 62% reduction in peak salbutamol levels. Low inspiratory flow led to a 52% reduction in peak salbutamol levels and a 78% reduction in trough levels. Missed doses led to a 37% reduction in trough salbutamol levels. CONCLUSIONS: These findings confirm that technique errors affect drug delivery. Furthermore, we were able to identify that the most critical technique errors with the Diskus inhaler are exhalation into the device before inhalation, poor inspiratory flow, and missing doses.
Entities:
Keywords:
INCA; adherence; drug delivery; inhalers; salbutamol; technique error
Authors: Patrick K Gleeson; Luzmercy Perez; A Russell Localio; Knashawn H Morales; Xiaoyan Han; Tyra Bryant-Stephens; Andrea J Apter Journal: J Allergy Clin Immunol Pract Date: 2019-06-05
Authors: John D Blakey; Bruce G Bender; Alexandra L Dima; John Weinman; Guilherme Safioti; Richard W Costello Journal: Eur Respir J Date: 2018-11-22 Impact factor: 16.671
Authors: David J Collier; Pascal Wielders; Job van der Palen; Logan Heyes; Dawn Midwinter; Kathryn Collison; Andy Preece; Neil Barnes; Raj Sharma Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-06-09
Authors: Elizabeth Smith; Max Thomas; Ebru Calik-Kutukcu; Irene Torres-Sánchez; Maria Granados-Santiago; Juan Carlos Quijano-Campos; Karl Sylvester; Chris Burtin; Andreja Sajnic; Jana De Brandt; Joana Cruz Journal: ERJ Open Res Date: 2021-02-08
Authors: Johanna Sulku; Kristina Bröms; Marieann Högman; Christer Janson; Karin Lisspers; Andrei Malinovschi; Håkan Melhus; Björn Ställberg; Elisabet I Nielsen Journal: NPJ Prim Care Respir Med Date: 2021-02-09 Impact factor: 2.871
Authors: Terence E Taylor; Yaniv Zigel; Clarice Egan; Fintan Hughes; Richard W Costello; Richard B Reilly Journal: Sci Rep Date: 2018-02-01 Impact factor: 4.379